Announcements Trials
Browse Landscape

Status

Active not recruiting 9Recruiting 3Completed 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 51Neoplasms 45Colorectal Neoplasms 27Carcinoma, Non-Small-Cell Lung 22Prostatic Neoplasms 20Lung Neoplasms 16Leukemia, Myeloid, Acute 16Recurrence 12Multiple Myeloma 11Melanoma 11Stomach Neoplasms 10Head and Neck Neoplasms 10Ovarian Neoplasms 9Uterine Cervical Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 8Pancreatic Neoplasms 7Neoplasm Metastasis 7Myelodysplastic Syndromes 7Lymphoma 7Glioma 7Carcinoma, Renal Cell 7Brain Neoplasms 7Motor Activity 6Leukemia 6Hodgkin Disease 6Esophageal Neoplasms 6Colonic Neoplasms 6Carcinoma, Hepatocellular 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Rhabdoid Tumor × 30 days × Clear all
NCT03251989 2026-05-29

Rare CNS Tumors Outcomes &Risk

National Institutes of Health Clinical Center (CC)

Completed
326 enrolled
CNS

Brain Neoplasms, Ependymoma, Glioma, Medulloblastoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡